domingo, 1 de junio de 2025

Benefits Persist With Inavolisib in PIK3CA-Mutated Breast Cancer Kate Johnson May 23, 2025

https://www.medscape.com/viewarticle/benefits-persist-inavolisib-pik3ca-mutated-breast-cancer-2025a1000d1x?ecd=WNL_conf_onc_ASCO-SPON_250531_MSCPEDIT_etid7464020&uac=148436CN&impID=7464020

No hay comentarios:

Publicar un comentario